FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

373303004: Opiate agonist (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1198601014 Opiate agonist (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1478201014 Opiate agonist product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1490860012 Narcotic analgesic product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1490861011 Opioid product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Opiate agonist (substance) Is a Analgesic (substance) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dextromoramide 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Product containing precisely dihydrocodeine 30 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Dihydrocodeine tartrate 10mg/5mL elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    tartrate de dihydrocodéine 50 mg/mL, ampoule de 1 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Dihydrocodeine tartrate 60mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Dihydrocodeine tartrate 90mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Dihydrocodeine tartrate 120mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Product containing precisely dihydrocodeine 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Levacetylmethadol hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Product containing methadone analog The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Opiate agonist The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Remifentanil (substance) Is a False Opiate agonist (substance) Inferred relationship Some
    Dipipanone (substance) Is a False Opiate agonist (substance) Inferred relationship Some
    Methadone (substance) Is a False Opiate agonist (substance) Inferred relationship Some
    Alfentanil (substance) Is a False Opiate agonist (substance) Inferred relationship Some
    Oral fluid opiate level (procedure) Component False Opiate agonist (substance) Inferred relationship Some
    Urine methadone metabolite level (procedure) Component False Opiate agonist (substance) Inferred relationship Some
    Meptazinol (substance) Is a False Opiate agonist (substance) Inferred relationship Some
    Squill opiate (substance) Is a False Opiate agonist (substance) Inferred relationship Some
    Opium alkaloid (substance) Is a False Opiate agonist (substance) Inferred relationship Some
    Opioid intoxication delirium Causative agent (attribute) False Opiate agonist (substance) Inferred relationship Some
    Harmful pattern of use of opioid (disorder) Causative agent (attribute) False Opiate agonist (substance) Inferred relationship Some
    Product containing dihydrocodeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Opiates Component False Opiate agonist (substance) Inferred relationship Some
    Opioid-induced sexual dysfunction Causative agent (attribute) False Opiate agonist (substance) Inferred relationship Some
    Quantitative measurement of opiate agonist Component False Opiate agonist (substance) Inferred relationship Some
    Intoxication caused by opioid (disorder) Causative agent (attribute) False Opiate agonist (substance) Inferred relationship Some
    Opioid withdrawal Causative agent (attribute) False Opiate agonist (substance) Inferred relationship Some
    Product containing dextromoramide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Product containing opioid receptor agonist (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Product containing aspirin and caffeine and propoxyphene hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some
    Product containing paracetamol and propoxyphene napsylate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist (substance) Inferred relationship Some

    Start Page 2 of 2

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start